These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11935432)

  • 1. Short-term chlorambucil for refractory uveitis in Behcet's disease.
    Mudun BA; Ergen A; Ipcioglu SU; Burumcek EY; Durlu Y; Arslan MO
    Ocul Immunol Inflamm; 2001 Dec; 9(4):219-29. PubMed ID: 11935432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorambucil and cyclosporine A in Brazilian patients with Behçet's disease uveitis: a retrospective study.
    Zaghetto JM; Yamamoto MM; Souza MB; Silva FT; Hirata CE; Olivalves E; Yamamoto JH
    Arq Bras Oftalmol; 2010; 73(1):40-6. PubMed ID: 20464112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
    Interlandi E; Leccese P; Olivieri I; Latanza L
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S58-62. PubMed ID: 25005224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
    Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts Eye and Ear Infirmary experience.
    Miserocchi E; Baltatzis S; Ekong A; Roque M; Foster CS
    Ophthalmology; 2002 Jan; 109(1):137-42. PubMed ID: 11772593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value and complications of immunosuppressive therapy in uveitis of Behcet's disease or of other etiology. Apropos of 40 cases].
    Niessen F; Campinchi R; Bloch-Michel E
    J Fr Ophtalmol; 1982; 5(6-7):407-16. PubMed ID: 7130629
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical observation of 85 patients with Behçet's uveitis treated with immunosuppressive agents combined with steroids].
    Zhao M; Wang H; Jiao X; Wei WB
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):202-6. PubMed ID: 23866699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.
    Buggage RR; Levy-Clarke G; Sen HN; Ursea R; Srivastava SK; Suhler EB; Altemare C; Velez G; Ragheb J; Chan CC; Nussenblatt RB; Bamji AT; Sran P; Waldmann T; Thompson DJ
    Ocul Immunol Inflamm; 2007; 15(2):63-70. PubMed ID: 17558830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
    Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet's disease.
    O'Duffy JD; Robertson DM; Goldstein NP
    Am J Med; 1984 Jan; 76(1):75-84. PubMed ID: 6691363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.
    Takeuchi M; Kezuka T; Sugita S; Keino H; Namba K; Kaburaki T; Maruyama K; Nakai K; Hijioka K; Shibuya E; Komae K; Hori J; Ohguro N; Sonoda KH; Mizuki N; Okada AA; Ishibashi T; Goto H; Mochizuki M
    Ophthalmology; 2014 Oct; 121(10):1877-84. PubMed ID: 24950593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients.
    Lee JH; Lee CS; Lee SC
    BMC Ophthalmol; 2018 Feb; 18(1):52. PubMed ID: 29463220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of infliximab in patients with Behçet's disease-associated uveitis.
    Yamana S; Hasegawa E; Takeda A; Yawata N; Sonoda KH
    Int Ophthalmol; 2023 Mar; 43(3):937-944. PubMed ID: 36057758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes.
    Amer R; Alsughayyar W; Almeida D
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1423-1432. PubMed ID: 28396946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behçet's disease ocular attack score 24 and visual outcome in patients with Behçet's disease.
    Tanaka R; Murata H; Takamoto M; Ohtomo K; Okinaga K; Yoshida A; Kawashima H; Nakahara H; Fujino Y; Kaburaki T
    Br J Ophthalmol; 2016 Jul; 100(7):990-994. PubMed ID: 26553921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients.
    Bodaghi B; Gendron G; Wechsler B; Terrada C; Cassoux N; Huong du LT; Lemaitre C; Fradeau C; LeHoang P; Piette JC
    Br J Ophthalmol; 2007 Mar; 91(3):335-9. PubMed ID: 17050581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease.
    Gueudry J; Wechsler B; Terrada C; Gendron G; Cassoux N; Fardeau C; Lehoang P; Piette JC; Bodaghi B
    Am J Ophthalmol; 2008 Dec; 146(6):837-44.e1. PubMed ID: 19027420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveitis in juvenile Behçet's disease: clinical course and visual outcome compared with adult patients.
    Kramer M; Amer R; Mukamel M; Snir M; Jaouni T; Friling R
    Eye (Lond); 2009 Nov; 23(11):2034-41. PubMed ID: 19151650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of infliximab on background vascular leakage in patients with Behçet's disease.
    Keino H; Okada AA; Watanabe T; Taki W
    Eye (Lond); 2014 Sep; 28(9):1100-6. PubMed ID: 24946845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuro-Behçet: a follow-up of 4 cases treated with chlorambucil].
    Mateos-Colino A; Gonzalez-Gay MA; Cereijo MJ; Santiago J; Rabuñal R; Brañas F
    An Med Interna; 1995 Dec; 12(12):600-2. PubMed ID: 8679804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.